Lexaria Bioscience logo

Lexaria Bioscience

LEXX | NASDAQ
Chart Builder DCF Calculator
$4.41
-$0.03 (-0.68%)
At close: Nov 16, 2026, 4:00 PM ET
$4.11
-$0.30 (-6.80%)
After-hours: Nov 16, 2026, 4:23 PM ET
-0.68%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
29
Fundamentals Weak
Market Sentiment Neutral
Moat Narrow
Sector Rank #834/1021 (Top 82%)

Key Statistics

Market Data

Market Cap $7.29M
1D Range
4.00 4.48
52W Range
2.60 20.10

Valuation (TTM)

PE -0.83
PB 1.54
EV/EBITDA -0.49

Valuation (NTM)

Forward PE N/A
Forward PEG -0.06
Price Target $1.50
Loading financial charts...

Profile

Lexaria Bioscience Corp. is a biotechnology company focused on advanced drug delivery. Its proprietary and patented DehydraTECH technology is designed to significantly improve the oral delivery of act...

Sector Healthcare
Industry Biotechnology
Employees 7
IPO Date Jan 12, 2021
Fiscal Year September - August

Latest News

No news articles available yet.

Earnings

Next Earnings
Nov 24, 2026
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$1.50
Downside
-65.99%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.